L Biedermann, K Kerl, G Rogler, G F L Hofbauer. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Antibodies, Monoclonal, Humanized/administration & dosageAntibodies, Monoclonal, Humanized/adverse effectsCertolizumab PegolCrohn Disease/drug therapyErythema Nodosum/chemically inducedErythema Nodosum/drug therapyFemaleHumansImmunoglobulin Fab Fragments/administration & dosageImmunoglobulin Fab Fragments/adverse effectsImmunosuppressive Agents/administration & dosageImmunosuppressive Agents/adverse effectsMiddle AgedPolyethylene Glycols/administration & dosagePolyethylene Glycols/adverse effectsPrognosis
Substances： See more » Antibodies, Monoclonal, HumanizedImmunoglobulin Fab FragmentsImmunosuppressive AgentsPolyethylene GlycolsCertolizumab Pegol
Year: 2013 PMID： 22127817 DOI： 10.1002/ibd.21942
Source DB: PubMed Journal: Inflamm Bowel Dis ISSN： 1078-0998 Impact factor: 5.325